Reclast, the first once-a-YEAR bisphosphonate infusion for postmenopausal osteoporosis

September 2007

View FDA's preliminary statement concerning bisphosphonates and atrial fibrillation

Women will be asking about Reclast, the first once-a-YEAR bisphosphonate infusion for postmenopausal osteoporosis.

Reclast (zoledronic acid) is already approved for Paget's disease. Zoledronic acid is also what's in Zometa for cancer patients.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

More patients should now get vaccines for meningitis, hepatitis A, varicella, pertussis, and influenza
Osteoporosis Reclast, the first once-a-YEAR bisphosphonate infusion for postmenopausal osteoporosis
ADHD Some Daytrana (methylphenidate) patches are falling off
Infectious Diseases new HIV drug, Selzentry (maraviroc)
Gastroenterology Prilosec and Nexium might cause heart problems
Gastroenterology Zelnorm (tegaserod) is back, but only for certain patients
Geriatrics misuse of the Beers criteria to determine drug therapy in the elderly
Psychiatry Exelon (rivastigmine) now comes in a once-daily PATCH
Ophthalmology eyedrop called AzaSite for bacterial conjunctivitis, or "pink eye"
Respiratory & Allergy new Rx antihistamine called Xyzal (ZEYE-zol)
Respiratory & Allergy Zyflo CR, a new extended-release version of zileuton for chronic asthma
Diabetes whether patients with type 2 diabetes benefit from monitoring their blood glucose
Diabetes how to treat diabetes during pregnancy
new requirement to use tamper-resistant pads for most written Medicaid prescriptions